France· FR:68906518
ZILBRYSQ 16,6 mg, solution injectable en seringue préremplie
A zilucoplan product containing zilucoplan sodique, registered in France by UCB PHARMA BELGIQUE, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Zilucoplan is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AJ06 (zilucoplan), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Zilucoplan · ATC L04AJ06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ZILUCOPLAN SODIQUE
- Manufacturer
- UCB PHARMA BELGIQUE
- Country
- France (FR)
- ATC code
- L04AJ06
- ATC class
- Zilucoplan
- Defined daily dose
- 23 mg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302808987 seringues préremplies en verre avec dispositif de sécurité de 0,416 mLEUR 3.91
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zilucoplan in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsZilbrysq 16,6 mg oplossing voor injectie in een voorgevulde penUCB Pharma S.A.
- IrelandZilbrysq 16.6 mg solution for injection in pre-filled syringeUCB Pharma S.A.
- CzechiaZILBRYSQUCB Pharma SA, Brusel
- SpainZILBRYSQ 16,6 MG SOLUCION INYECTABLE EN PLUMA PRECARGADAUcb Pharma
- FinlandZilbrysqUCB Pharma SA
- BelgiumZilbrysq 16.6 mgUCB Pharma
- SwedenZILBRYSQ 16,6 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- PolandZilbrysqUCB Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zilbrysq
- Liechtenstein · Zilbrysq
- Norway · Zilbrysq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/80dacc38-2608-41f0-b02c-69ad9d4a8fc4 GET /v1/drugs/80dacc38-2608-41f0-b02c-69ad9d4a8fc4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68906518",
"date_amm": "2023-12-01",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/23/1764",
"substance": "ZILUCOPLAN SODIQUE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about zilucoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.